Control of selective estrogen receptor modulators
US7256185B1 · kind B1 · utility
0Cited by
4References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 18, 1999 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | Feb 4, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The treatment of an estrogen sensitive condition by the administration of a selective estrogen receptor modulator is improved by additionally administering a progestationally active compound to the recipient. The additional agent can express both progestational and androgenic activity or an androgenically active material can be employed, if desired. Additionally, clomiphene in an array of isomeric ratios (EN:ZU) can be used alone for prevention of osteoporosis, maintenance of a healthful blood lipid profile, and prevention of breast tumors, or to sustain amenorrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.